Across TCGA pan-cancer cohorts, RNY3P11 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RNY3P11’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where RNY3P11 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNY3P11 is over-expressed in tumor.

STAD and LUSC are the cancer types where RNY3P11 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNY3P11 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Male	All	+0.888	.002	5	view →
LUSC	All	All	+0.100	.016	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: RNY3P11 RNA expression & survival · all RNY3P11 data types